Amersham sells remaining Nycomed stake

Amersham (LSE:NAM; NYE) sold its remaining stake in Nycomed Pharma (Oslo, Norway) for L123 million ($179 million) to Nordic Capital, the holding company of Nycomed. Since 1999, NAM has made in total L...